Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire Harrison

Showing results (41-50 of 218) with videos related to

Pageof 22
Sort By:
BMJ (Clinical Research Ed.)|November 20, 2013
The diagnosis and management of erythrocytosisClodagh Keohane, Mary Frances McMullin, Claire Harrison
Expert Review of Hematology|November 4, 2024
What are the therapeutic options for previously treated myelofibrosis?Cassandre Petit, Hugues de Lavallade, Claire Harrison
Journal of Clinical Pathology|March 31, 2012
Positive JAK2-V617F leading to diagnosis of Gaucher's diseaseStella Appiah-Cubi, Bridget S Wilkins, Claire Harrison
Transfusion|November 18, 2003
Management of pregnancy complicated by anti-DibNay Win, Bella Madan, Claire Harrison, et al.
Blood Advances|April 29, 2020
Fedratinib in myelofibrosisAnn Mullally, John Hood, Claire Harrison, et al.
Public Health Nutrition|July 7, 2011
Re-imagining the 'social' in the nutrition sciencesLisa Schubert, Danielle Gallegos, Wendy Foley, et al.
Haematologica|April 4, 2020
Bone marrow niche dysregulation in myeloproliferative neoplasmsNatalia Curto-Garcia, Claire Harrison, Donal P McLornan
British Journal of Haematology|April 3, 2012
Janus kinase inhibition and its effect upon the therapeutic landscape for myelofibrosis: from palliation to cure?Claire Harrison, Srdan Verstovsek, Mary F McMullin, et al.
Current Hematologic Malignancy Reports|July 3, 2023
A Journey Through JAK Inhibitors for the Treatment of Myeloproliferative DiseasesAndrea Duminuco, Elena Torre, Giuseppe A Palumbo, et al.
Applied and Environmental Microbiology|October 23, 2024
Convergent reductive evolution in bee-associated lactic acid bacteriaAna Pontes, Marie-Claire Harrison, Antonis Rokas, et al.
Pageof 22

Showing results (41-50 of 218) with videos related to

Sort By:
Pageof 22
BMJ (Clinical Research Ed.)|November 20, 2013
The diagnosis and management of erythrocytosisClodagh Keohane, Mary Frances McMullin, Claire Harrison
Expert Review of Hematology|November 4, 2024
What are the therapeutic options for previously treated myelofibrosis?Cassandre Petit, Hugues de Lavallade, Claire Harrison
Journal of Clinical Pathology|March 31, 2012
Positive JAK2-V617F leading to diagnosis of Gaucher's diseaseStella Appiah-Cubi, Bridget S Wilkins, Claire Harrison
Transfusion|November 18, 2003
Management of pregnancy complicated by anti-DibNay Win, Bella Madan, Claire Harrison, et al.
Blood Advances|April 29, 2020
Fedratinib in myelofibrosisAnn Mullally, John Hood, Claire Harrison, et al.
Public Health Nutrition|July 7, 2011
Re-imagining the 'social' in the nutrition sciencesLisa Schubert, Danielle Gallegos, Wendy Foley, et al.
Haematologica|April 4, 2020
Bone marrow niche dysregulation in myeloproliferative neoplasmsNatalia Curto-Garcia, Claire Harrison, Donal P McLornan
British Journal of Haematology|April 3, 2012
Janus kinase inhibition and its effect upon the therapeutic landscape for myelofibrosis: from palliation to cure?Claire Harrison, Srdan Verstovsek, Mary F McMullin, et al.
Current Hematologic Malignancy Reports|July 3, 2023
A Journey Through JAK Inhibitors for the Treatment of Myeloproliferative DiseasesAndrea Duminuco, Elena Torre, Giuseppe A Palumbo, et al.
Applied and Environmental Microbiology|October 23, 2024
Convergent reductive evolution in bee-associated lactic acid bacteriaAna Pontes, Marie-Claire Harrison, Antonis Rokas, et al.
Pageof 22